View Older Stories View More Recent Stories
-
Form SC 13G/A PERNIX THERAPEUTICS HOLD Filed by: Broadfin Capital, LLC
-
Form SC 13G/A LA JOLLA PHARMACEUTICAL Filed by: Broadfin Capital, LLC
-
Form SC 13G DEXTERA SURGICAL INC Filed by: Broadfin Capital, LLC
-
PlacementTracker Publishes 2016 Private Placement Market League Tables
-
Form SC 13D/A DERMA SCIENCES, INC. Filed by: Broadfin Capital, LLC
-
Form SC 13G Mirati Therapeutics, Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Mirati Therapeutics, Filed by: Broadfin Capital, LLC
-
Form SC 13G/A AVADEL PHARMACEUTICALS Filed by: Broadfin Capital, LLC
-
Form SC 13G AVADEL PHARMACEUTICALS Filed by: Broadfin Capital, LLC
-
Strongbridge Biopharma (SBBP) Enters $35M Securities Purchase Agreement
-
Strongbridge Biopharma plc Provides Corporate and Financial Update
-
Strongbridge Biopharma plc Announces $35 Million Equity Financing
-
Form SC 13D/A Recro Pharma, Inc. Filed by: Broadfin Capital, LLC
-
Form SC 13D/A QLT INC/BC Filed by: Broadfin Capital, LLC
-
Form SC 13D/A Aegerion Pharmaceuticals Filed by: Broadfin Capital, LLC
-
Aegerion Pharma (AEGR), QLT, Inc. (QLTI) Announce Completion of Merger; Name Changes to 'Novelion Therapeutics'
-
Aegerion Pharmaceuticals, Inc. and QLT Inc. Complete Merger Transaction; QLT to Change Name to Novelion Therapeutics Inc.
-
Form SC 13G DURECT CORP Filed by: Broadfin Capital, LLC
-
Form 13F-HR Broadfin Capital, LLC For: Sep 30
-
Form SC 13G VERACYTE, INC. Filed by: Broadfin Capital, LLC
-
PlacementTracker Publishes Q3 2016 Private Placement Market League Tables
-
Form SC 13D/A QLT INC/BC Filed by: Broadfin Capital, LLC
-
Form SC 13D/A Aegerion Pharmaceuticals Filed by: Broadfin Capital, LLC
-
Form SC 13D/A QLT INC/BC Filed by: Broadfin Capital, LLC
-
Form SC 13D/A Recro Pharma, Inc. Filed by: Broadfin Capital, LLC
-
Form 13F-HR Broadfin Capital, LLC For: Jun 30
-
Form SC 13G Mirati Therapeutics, Filed by: Broadfin Capital, LLC
-
Lion Biotechnologies Announces Second Quarter 2016 Financial Results
-
Form SC 13D Aegerion Pharmaceuticals Filed by: Broadfin Capital, LLC
-
Form SC 13D QLT INC/BC Filed by: Broadfin Capital, LLC
-
Notable Mergers and Acquisitions 6/15: (EBIX)/(PN) (AEGR)/(QLTI) (DYN) (CBYL) (BBBY)
-
QLT Inc. (QLTI), Aegerion Pharma (AEGR) Enter Strategic Merger Agreement
-
Aegerion Pharmaceuticals and QLT Inc. Agree to Strategic Merger
-
Unusual 11 Mid-Day Movers 6/3: (LBIO) (EBIO) (JVA) Higher; (GSAT) (GOGO) (IMMU) Lower
-
Lion Biotechnologies (LBIO) Names Maria Fardis, Ph.D., as CEO; Board Appointments Announced
-
Lion Biotechnologies Appoints Maria Fardis, Ph.D., as CEO
-
Form 13F-HR Broadfin Capital, LLC For: Mar 31
-
Form SC 13G Aralez Pharmaceuticals Filed by: Broadfin Capital, LLC
-
Form SC 13D/A STRATA Skin Sciences, Filed by: Broadfin Capital, LLC
-
ContraFect Announces Fourth Quarter and Full Year 2015 Results
-
Form SC 13G/A PERNIX THERAPEUTICS HOLD Filed by: Broadfin Capital, LLC
-
Form SC 13G NEVRO CORP Filed by: Broadfin Capital, LLC
-
Form SC 13G CARDICA INC Filed by: Broadfin Capital, LLC
-
RedHill Biopharma Reports 2015 Fourth Quarter and Full-Year Financial Results
-
Form 13F-HR Broadfin Capital, LLC For: Dec 31
-
Form SC 13G/A PROGENICS PHARMACEUTICAL Filed by: Broadfin Capital, LLC
-
Form SC 13G/A NOVADAQ TECHNOLOGIES Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Eleven Biotherapeutics, Filed by: Broadfin Capital, LLC
-
Form SC 13G/A CONTRAFECT Corp Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Ohr Pharmaceutical Inc Filed by: Broadfin Capital, LLC

